{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T19:22:27Z","timestamp":1773170547901,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The performance of liver stiffness measurements (LSMs) obtained using FibroScan can be affected by several factors, and cut-off values are different for fibrosis caused by various aetiologies. The study aims to evaluate the diagnostic accuracy of LSM in nonalcoholic fatty liver disease (NAFLD) patients with abnormal glucose metabolism and investigate whether the LSM value would be affected by metabolic indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study involved 91 NAFLD patients with abnormal glucose metabolism who underwent liver biopsy. The diagnostic accuracy of LSM value was evaluated by the receiver operator characteristic (ROC) curves, with the biopsy results taken as the gold standard. Multivariate linear regression and subgroup analysis were performed to determine the correlated indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The areas under the ROC curves (AUROCs) of LSM values for detecting fibrosis stage \u22651, 2, 3 and 4 were 0.793 (95% confidence interval [CI]: 0.695\u20130.871), 0.764 (95% CI: 0.663\u20130.846), 0.837 (95% CI: 0.744\u20130.906) and 0.902 (95% CI: 0.822\u20130.955), with cut-off values of 6.3, 7.6, 8.3 and 13.8\u2009kPa, respectively. Multivariate linear regression demonstrated that haemoglobin A1c (HbA1c, \u03b2\u2009=\u20090.205,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.026) and alanine aminotransferase (ALT, \u03b2\u2009=\u20090.192,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.047) were independently associated with the LSM value after adjustment for fibrosis stage, ballooning and inflammation grade from liver biopsy. Subgroup analysis demonstrated that LSM values were slightly higher in patients with HbA1c \u22657% than in those with HbA1c &lt;\u20097% and in patients with body mass index (BMI) \u226530\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      than in those with BMI &lt;\u200930\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>FibroScan was valuable for the evaluation of liver fibrosis in NAFLD patients with abnormal glucose metabolism. FibroScan is recommended to evaluate severe fibrosis, especially to exclude advanced fibrosis. Glucose metabolism state may affect LSM values.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-021-01453-5","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T04:02:38Z","timestamp":1616472158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Xinyu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengdi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuzhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengxiang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingfeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7341-4368","authenticated-orcid":false,"given":"Hongmei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"issue":"7","key":"1453_CR1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322. https:\/\/doi.org\/10.1038\/s41591-018-0104-9.","journal-title":"Nat Med"},{"issue":"7","key":"1453_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","volume":"15","author":"QM Anstee","year":"2018","unstructured":"Anstee QM, Mantovani A, Tilg H, Targher G. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2018;15(7):425\u201339. https:\/\/doi.org\/10.1038\/s41575-018-0010-0.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"1453_CR3","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138\u201353. https:\/\/doi.org\/10.1136\/gutjnl-2017-313884.","journal-title":"Gut."},{"issue":"1","key":"1453_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology."},{"issue":"1","key":"1453_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32\u201342. https:\/\/doi.org\/10.1038\/nrgastro.2016.147.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1453_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124\u201331. https:\/\/doi.org\/10.1053\/j.gastro.2010.09.038.","journal-title":"Gastroenterology."},{"issue":"4","key":"1453_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, Qiu Y, Burns L, Afendy A, Nader F. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793\u2013801. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.021.","journal-title":"J Hepatol"},{"issue":"2","key":"1453_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A, Haflidadottir S, Bendtsen F. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389\u201397 e310. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.043.","journal-title":"Gastroenterology."},{"issue":"6","key":"1453_CR9","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","volume":"67","author":"H Hagstrom","year":"2017","unstructured":"Hagstrom H, Nasr P, Ekstedt M, Hammar U, St\u00e5l P, Hultcrantz R, et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol. 2017;67(6):1265\u201373. https:\/\/doi.org\/10.1016\/j.jhep.2017.07.027.","journal-title":"J Hepatol"},{"issue":"4","key":"1453_CR10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4158\/EP-2019-0342","volume":"26","author":"H Bian","year":"2020","unstructured":"Bian H, Zhu X, Xia M, Yan H, Chang X, Hu X, Pan B, Guo W, Li X, Gao X. Impact of type 2 diabetes on nonalcoholic steatohepatitis and advanced fibrosis in patients with nonalcoholic fatty liver disease. Endocr Pract. 2020;26(4):444\u201353. https:\/\/doi.org\/10.4158\/EP-2019-0342.","journal-title":"Endocr Pract"},{"issue":"8","key":"1453_CR11","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1097\/TP.0000000000001709","volume":"101","author":"C Bhati","year":"2017","unstructured":"Bhati C, Idowu MO, Sanyal AJ, Rivera M, Driscoll C, Stravitz RT, Kohli DR, Matherly S, Puri P, Gilles HC, Cotterell A, Levy M, Sterling RK, Luketic VA, Lee H, Sharma A, Siddiqui MS. Long-term outcomes in patients undergoing liver transplantation for nonalcoholic Steatohepatitis-related cirrhosis. Transplantation. 2017;101(8):1867\u201374. https:\/\/doi.org\/10.1097\/TP.0000000000001709.","journal-title":"Transplantation."},{"issue":"5","key":"1453_CR12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, Stal P, Wong VWS, Kechagias S, Hultcrantz R, Loomba R. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65(5):1557\u201365. https:\/\/doi.org\/10.1002\/hep.29085.","journal-title":"Hepatology."},{"issue":"6","key":"1453_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/jhep.2003.09022","volume":"38","author":"P Bedossa","year":"2003","unstructured":"Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38(6):1449\u201357. https:\/\/doi.org\/10.1053\/jhep.2003.09022.","journal-title":"Hepatology."},{"issue":"5","key":"1453_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1478-3231.2008.01693.x","volume":"28","author":"JKJ Gaidos","year":"2008","unstructured":"Gaidos JKJ, Hillner BE, Sanyal AJ. A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis. Liver Int. 2008;28(5):650\u20138. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01693.x.","journal-title":"Liver Int"},{"issue":"7","key":"1453_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJM200102153440706","volume":"344","author":"AA Bravo","year":"2001","unstructured":"Bravo AA. Sheth Sg Fau - Chopra S, Chopra S. Liver biopsy N Engl J Med. 2001;344(7):495\u2013500. https:\/\/doi.org\/10.1056\/NEJM200102153440706.","journal-title":"Liver biopsy N Engl J Med"},{"issue":"1","key":"1453_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357. https:\/\/doi.org\/10.1002\/hep.29367.","journal-title":"Hepatology."},{"key":"1453_CR17","first-page":"w20077","volume":"149","author":"S Baumeler","year":"2019","unstructured":"Baumeler S, Jochum W, Neuweiler J, Bergamin I, Semela D. Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-Centre real life experience. Swiss Med Wkly. 2019;149:w20077.","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"1453_CR18","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","volume":"150","author":"K Imajo","year":"2016","unstructured":"Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150(3):626\u201337 e627. https:\/\/doi.org\/10.1053\/j.gastro.2015.11.048.","journal-title":"Gastroenterology."},{"issue":"32","key":"1453_CR19","doi-asserted-by":"publisher","first-page":"7236","DOI":"10.3748\/wjg.v22.i32.7236","volume":"22","author":"I Mikolasevic","year":"2016","unstructured":"Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography (FibroScan((R))) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - where do we stand? World J Gastroenterol. 2016;22(32):7236\u201351. https:\/\/doi.org\/10.3748\/wjg.v22.i32.7236.","journal-title":"World J Gastroenterol"},{"issue":"16","key":"1453_CR20","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.3748\/wjg.v20.i16.4702","volume":"20","author":"F Shen","year":"2014","unstructured":"Shen F, Zheng RD, Mi YQ, Fan JG, Mi YQ, L\u00e9dinghen V, et al. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. World J Gastroenterol. 2014;20(16):4702\u201311. https:\/\/doi.org\/10.3748\/wjg.v20.i16.4702.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1453_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/hep.24121","volume":"53","author":"KS Jung","year":"2011","unstructured":"Jung KS, Kim SU, Ahn SH, Park YN, Kim DY, Park JY, Chon CY, Choi EH, Han KH. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology. 2011;53(3):885\u201394. https:\/\/doi.org\/10.1002\/hep.24121.","journal-title":"Hepatology."},{"issue":"5","key":"1453_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ajg.2016.49","volume":"111","author":"EB Tapper","year":"2016","unstructured":"Tapper EB, Challies T, Nasser I, Afdhal NH, Lai M. The performance of vibration controlled transient elastography in a US cohort of patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2016;111(5):677\u201384. https:\/\/doi.org\/10.1038\/ajg.2016.49.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1453_CR23","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, Bedossa P, Newsome PN. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717\u201330. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.042.","journal-title":"Gastroenterology."},{"key":"1453_CR24","unstructured":"Chinese Foundation for Hepatitis Prevention and Control; Chinese Society of Infectious Disease and Chinese Society of Hepatology, Chinese Medical Association; Liver Disease Committee of Chinese Research Hospital Association. Consensus on clinical application of transient elastography detecting liver fibrosis: a 2018 update. Chin J Hepatol. 2019;27:182\u201391."},{"issue":"6","key":"1453_CR25","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313\u201321. https:\/\/doi.org\/10.1002\/hep.20701.","journal-title":"Hepatology."},{"issue":"18","key":"1453_CR26","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR, NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362(18):1675\u201385. https:\/\/doi.org\/10.1056\/NEJMoa0907929.","journal-title":"N Engl J Med"},{"issue":"12","key":"1453_CR27","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","volume":"29","author":"L Sandrin","year":"2003","unstructured":"Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, Beaugrand M, Palau R. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705\u201313. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2003.07.001.","journal-title":"Ultrasound Med Biol"},{"issue":"6","key":"1453_CR28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/HJH.0000000000002453","volume":"38","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. 2020 international society of hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982\u20131004. https:\/\/doi.org\/10.1097\/HJH.0000000000002453.","journal-title":"J Hypertens"},{"key":"1453_CR29","doi-asserted-by":"publisher","unstructured":"Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20(7):1183\u201397. https:\/\/doi.org\/10.2337\/diacare.20.7.1183.","DOI":"10.2337\/diacare.20.7.1183"},{"issue":"11","key":"1453_CR30","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","volume":"26","author":"S Genuth","year":"2003","unstructured":"Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160\u20137. https:\/\/doi.org\/10.2337\/diacare.26.11.3160.","journal-title":"Diabetes Care"},{"issue":"6","key":"1453_CR31","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.ultrasmedbio.2015.01.011","volume":"41","author":"X Zeng","year":"2015","unstructured":"Zeng X, Xu C, He D, Zhang H, Xia J, Shi D, Kong L, He X, Wang Y. Influence of hepatic inflammation on fibroScan findings in diagnosing fibrosis in patients with chronic hepatitis B. Ultrasound Med Biol. 2015;41(6):1538\u201344. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2015.01.011.","journal-title":"Ultrasound Med Biol"},{"key":"1453_CR32","doi-asserted-by":"publisher","unstructured":"Wong GL, Wong VW, Chim AM, Yiu KK, Chu SH, Li,MK, et al. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol 2011;26:300\u2013305, 2, DOI: https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06510.x.","DOI":"10.1111\/j.1440-1746.2010.06510.x"},{"issue":"11","key":"1453_CR33","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1111\/liv.12809","volume":"35","author":"F Shen","year":"2015","unstructured":"Shen F, Zheng RD, Shi JP, Mi YQ, Chen GF, Hu X, Liu YG, Wang XY, Pan Q, Chen GY, Chen JN, Xu L, Zhang RN, Xu LM, Fan JG. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease. Liver Int. 2015;35(11):2392\u2013400. https:\/\/doi.org\/10.1111\/liv.12809.","journal-title":"Liver Int"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01453-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-021-01453-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01453-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T04:06:35Z","timestamp":1616472395000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01453-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1453"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01453-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-139291\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-139291\/v2","asserted-by":"object"}]},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"29 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because only the medical records were reviewed, this case series was exempted from signing informed consent, which was approved by the Human Research Ethics Committee of Zhongshan Hospital Clinic (B2021-130).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest for the research conducted in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}